LASCO Pharmaceutical, Bayer launch drug to treat chronic kidney disease
Bayer Healthcare, in partnership with LASCO Pharmaceutical Division, has introduced finerenone, a groundbreaking drug, branded as Firialta, for the treatment of chronic kidney disease (CKD). It is estimated that 300,000 Jamaicans, approximately 10...
Source: jamaica-gleaner.com